Alzheimers patients could benefit from vitamin E supplements 21 April 2008
An intake of vitamin E supplements has been linked to the longevity of Alzheimer’s patients in a study presented at the American Academy of Neurology Annual Meeting in Chicago.
The study followed 847 people with Alzheimer’s disease for an average of 4.9 years and results show that vitamin E could potentially improve the survival of people suffering from the disease.
Researchers reported that approximately 66 per cent of subjects consumed the recommended daily dose of vitamin E twice a day along with an Alzheimer´s drug (a cholinesterase inhibitor), less than 10 per cent of the group took vitamin E alone, while about 15 per cent consumed no vitamin E.
Consumption of the vitamin, with or without a cholinesterase inhibitor, was associated with a 26 per cent reduction in all-cause mortality than those who didn´t take vitamin E. In addition, results suggested that vitamin E plus a cholinesterase inhibitor may be more beneficial than taking either agent alone.
Consumption of the vitamin, with or without a cholinesterase inhibitor, was associated with a 26 per cent reduction in all-cause mortality than those who didn´t take vitamin E. In addition, results suggested that vitamin E plus a cholinesterase inhibitor may be more beneficial than taking either agent alone.
Alzheimer´s disease is the most common form of dementia and currently affects over 13 million people worldwide.
